TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16304073

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 9978

Group type: COMPARATOR
Intervention: Unfractionated heparin
Number of subjects: 9978

Group type: EXPERIMENTAL
Intervention: Enoxaparin (consistent therapy)
Number of subjects: 9978

Group type: COMPARATOR
Intervention: Unfractionated heparin (consistent therapy)
Number of subjects: 9978
Study: 11967499

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) 0.625 mg
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: CEE plus medroxyprogesterone acetate (MPA) 2.5 mg
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 9815234

Group type: EXPERIMENTAL
Intervention: HHV‐6 reactivation
Number of subjects: 53

Group type: COMPARATOR
Intervention: CMVIG prophylaxis
Number of subjects: 53
Study: 7716850

Group type: EXPERIMENTAL
Intervention: Color Doppler ultrasound
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Gray-scale ultrasound
Number of subjects: 9
Study: 2654254

Group type: EXPERIMENTAL
Intervention: Hydroxyzine (Atarax; Roerig, New York, N.Y.)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Ketotifen (Zaditen; Sandoz Pharmaceuticals, Basel, Switzerland)
Number of subjects: 8
Study: 6109503

Group type: EXPERIMENTAL
Intervention: Ringer Lactate (Group A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextran 60,000 (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 0
Study: 31728628

Group type: EXPERIMENTAL
Intervention: Double-plasma filtration (PF)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Prior to PF
Number of subjects: 16
Study: 30500464

Group type: EXPERIMENTAL
Intervention: w‐SPIINA (web‐based Spine Platform featuring Interaction and Information by Animation)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Standard information regimen (Control)
Number of subjects: 114
Study: 28241154

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 249

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 249

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: True acupuncture vs Sham acupuncture
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: True acupuncture vs Waiting-list
Number of subjects: 249

Group type: COMPARATOR
Intervention: Sham acupuncture vs Waiting-list
Number of subjects: 249
Study: 26028120

Group type: EXPERIMENTAL
Intervention: Continued methadone treatment
Number of subjects: 283

Group type: COMPARATOR
Intervention: Forced withdrawal from methadone (usual care)
Number of subjects: 283
Study: 23447518

Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study: 20878497

Group type: EXPERIMENTAL
Intervention: Language-concordant physicians
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Language-discordant physicians
Number of subjects: 510

Group type: COMPARATOR
Intervention: Latino English speakers
Number of subjects: 510

Group type: COMPARATOR
Intervention: LEP patients with language-concordant physicians vs Latino English speakers
Number of subjects: 510

Group type: COMPARATOR
Intervention: LEP patients with language-discordant physicians vs Latino English speakers
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: LEP patients with language-discordant physicians
Number of subjects: 510
Study: 19940325

Group type: EXPERIMENTAL
Intervention: Acute arm-cycling exercise
Number of subjects: 11
Study: 19133062

Group type: EXPERIMENTAL
Intervention: Topical application of diclofenac (30 mg total from two tapes)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Oral application of diclofenac (37.5 mg capsule)
Number of subjects: 14
Study: 16400897

Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg daily)
Number of subjects: 7241

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7241
Study: 12468570

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5 mg/d
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ramipril (escalated to 10 mg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Losartan (escalated to 100 mg/d)
Number of subjects: 20
Study: 9396874

Group type: EXPERIMENTAL
Intervention: Functional factor images
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fuzzy ROI curves
Number of subjects: 0
Study: 8684896

Group type: EXPERIMENTAL
Intervention: S2 stimuli Category C (semantically and physically different from S1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: S2 stimuli Category B (semantically the same but physically different from S1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: S2 stimuli Category A (the same as S1)
Number of subjects: 0
Study: 2483124

Group type: EXPERIMENTAL
Intervention: Intraoperative blood temperature of 20 degrees C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intraoperative blood temperature of 28 degrees C
Number of subjects: 20
Study: 326261

Group type: EXPERIMENTAL
Intervention: Piprozoline (Problin) therapy
Number of subjects: 1545

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1545
Study: 14622809

Group type: EXPERIMENTAL
Intervention: 25% sucrose
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: breast milk
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: sterile water
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: breast-feeding
Number of subjects: 130
Study: 30877773

Group type: EXPERIMENTAL
Intervention: Diphtheria/tetanus vaccination
Number of subjects: 284
Study: 29043904

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (N2O) as inhalant anesthesia
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no nitrous oxide)
Number of subjects: 86
Study: 27861344

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus FOLFIRI
Number of subjects: 2165

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus IFL
Number of subjects: 2165

Group type: COMPARATOR
Intervention: FOLFIRI or IFL alone
Number of subjects: 2165
Study: 24520783

Group type: EXPERIMENTAL
Intervention: Qingyi Chengqi Decoction (QCD)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine Western medicine (Control)
Number of subjects: 86
Study: 22582872

Group type: EXPERIMENTAL
Intervention: 12 mg Loperamide (LOP)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 12 mg Loperamide (LOP) + 125 mg Simethicone (SIM)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 18
Study: 20399022

Group type: EXPERIMENTAL
Intervention: Swing shift
Number of subjects: 19

Group type: COMPARATOR
Intervention: 14 consecutive night shifts
Number of subjects: 19
Study: 17538178

Group type: EXPERIMENTAL
Intervention: Emerging technologies for detection, characterization, and treatment of colorectal cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biology-directed laboratory investigations
Number of subjects: 0
Study: 16091274

Group type: EXPERIMENTAL
Intervention: Right hemisphere
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Left hemisphere
Number of subjects: 1
Study: 11830809

Group type: EXPERIMENTAL
Intervention: Arthroscopic‐assisted reduction and percutaneous cannulated screw fixation
Number of subjects: 5
Study: 10442280

Group type: EXPERIMENTAL
Intervention: TURP with a thick loop
Number of subjects: 36

Group type: COMPARATOR
Intervention: TURP with a standard loop
Number of subjects: 36
Study: 7842199

Group type: EXPERIMENTAL
Intervention: Inhaled bronchodilator (isoproterenol)
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Methacholine challenge test
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Factors indicating intrinsic airway reactivity
Number of subjects: 5887

Group type: EXPERIMENTAL
Intervention: Quality of spirometry testing factors
Number of subjects: 5887
Study: 2240505

Group type: EXPERIMENTAL
Intervention: Trimeprazine 3 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Trimeprazine 1.0 mg/kg, droperidol 0.15 mg/kg, methadone 0.08 mg/kg
Number of subjects: 100
Study: 319938

Group type: EXPERIMENTAL
Intervention: Guanabenz (2, 6‐dichlorobenzylidene aminoguanidine acetate) 4 to 16 mg twice daily
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 30448083

Group type: EXPERIMENTAL
Intervention: Grounding (Earthing) during work and sleep for four weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Not grounded (control group) for the first week and last week
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Grounding (Earthing) at one month follow-up
Number of subjects: 16
Study: 29242250

Group type: EXPERIMENTAL
Intervention: Bortezomib (1.3 mg/m2 intravenously on days 1, 4, 8, and 11, n=21)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (n=23)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 44
Study: 26854669

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin combined with metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional insulin therapy
Number of subjects: 0
Study: 23968339

Group type: EXPERIMENTAL
Intervention: D. farinae drops plus pharmacotherapy (treatment group)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Only pharmacotherapy (control group)
Number of subjects: 107
Study: 22331267

Group type: EXPERIMENTAL
Intervention: Gene expression profiling (specifically the overexpression of SNORD genes: SNORD25, SNORD27, SNORD30, and SNORD31)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chromosomal abnormalities detected by FISH and SNP‐arrays
Number of subjects: 0
Study: 20937743

Group type: EXPERIMENTAL
Intervention: FVL/PT mutation carriers
Number of subjects: 363

Group type: COMPARATOR
Intervention: FVL/PT non-carriers
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: FVL/PT mutations
Number of subjects: 363
Study: 17557339

Group type: EXPERIMENTAL
Intervention: Nonpharmacological therapy
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 17
Study: 15809950

Group type: EXPERIMENTAL
Intervention: Tourniquet pressure of 350 mm Hg
Number of subjects: 57

Group type: COMPARATOR
Intervention: Tourniquet pressure of systolic blood pressure (SBP) plus 100 mm Hg
Number of subjects: 57
Study: 11518845

Group type: EXPERIMENTAL
Intervention: Lacidipine (4-6 mg/daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Atenolol (50-100 mg/daily)
Number of subjects: 20
Study: 10205435

Group type: EXPERIMENTAL
Intervention: Cabbage leaf extract cream
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Feeding (not a cream intervention)
Number of subjects: 39
Study: 8172501

Group type: EXPERIMENTAL
Intervention: Early, intensive, supervised rehabilitation program (9 treatments combined with home exercises)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no specific physiotherapy treatment, only instructions and prescribed exercises)
Number of subjects: 31
Study: 2974259

Group type: EXPERIMENTAL
Intervention: Epidural dexamethasone (4 mg)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No steroid (group T)
Number of subjects: 39
Study: 31056239

Group type: EXPERIMENTAL
Intervention: Adductor canal (AC) catheter
Number of subjects: 151

Group type: COMPARATOR
Intervention: Femoral triangle (FT) catheter
Number of subjects: 151
Study: 29115200

Group type: EXPERIMENTAL
Intervention: 3 g high‐molecular weight (HMW) barley β‐glucan
Number of subjects: 30
Study: 25512446

Group type: EXPERIMENTAL
Intervention: Proportional Assist Ventilation (PAV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Assist Control Ventilation (ACV)
Number of subjects: 12
Study: 24289597

Group type: EXPERIMENTAL
Intervention: Phone call
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Short message by phone (SMS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Registered letter
Number of subjects: 100

Group type: COMPARATOR
Intervention: Postal letter
Number of subjects: 100
Study: 21466903

Group type: EXPERIMENTAL
Intervention: Home-based exercise program (HB); 40 min/session, at least three times per week, combined with slight caloric restriction of 100-300 calories per day.
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (CG); slight caloric restriction of 100-300 calories per day.
Number of subjects: 185
Study: 18649561

Group type: EXPERIMENTAL
Intervention: Fluoride gel
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fluoride rinse
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no topical fluoride agents)
Number of subjects: 30
Study: 16866587

Group type: EXPERIMENTAL
Intervention: Suppression of a preselected negative memory during a stream‐of‐consciousness (SOC) task
Number of subjects: 0

Group type: COMPARATOR
Intervention: No suppression condition (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suppression of memories
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants not asked to suppress memories
Number of subjects: 0
Study: 12670382

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 98

Group type: COMPARATOR
Intervention: Sham Acupressure
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study: 10833093

Group type: EXPERIMENTAL
Intervention: UDCA (600 mg/day) in addition to alpha‐IFN (3 MU three times weekly)
Number of subjects: 103
Study: 9234209

Group type: EXPERIMENTAL
Intervention: Pure rotation in place (180 deg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Linear motion (4.5 m)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Semicircular trajectory (radius, 1.5 m; angular acceleration, 0.2 rad s‐2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Passive movements
Number of subjects: 12
Study: 7535512

Group type: EXPERIMENTAL
Intervention: Topical tretinoin (0.1%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2455154

Group type: EXPERIMENTAL
Intervention: Lisinopril (20-80 mg, median 40 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nifedipine retard (40-80 mg, median 60 mg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 45
Study: 30197501

Group type: EXPERIMENTAL
Intervention: Canrenone 50 mg once a day for 1 month, then 100 mg once a day for 12 months
Number of subjects: 182

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 12.5 mg once a day for 1 month, then 25 mg once a day for 12 months
Number of subjects: 182
Study: 26747458

Group type: EXPERIMENTAL
Intervention: Chitosan (500 mg, five/day)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 24480637

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg pilsicainide hydrochloride
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.50 mg/kg pilsicainide hydrochloride
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.75 mg/kg pilsicainide hydrochloride
Number of subjects: 30
Study: 24059346

Group type: EXPERIMENTAL
Intervention: In-person, group-based intervention (9 modules delivered over 10 sessions)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Web-based intervention (13 modules)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Control group (mailed literature)
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: In-person, group-based intervention
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 660

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 660
Study: 20800632

Group type: EXPERIMENTAL
Intervention: ND-CCK (Normal Diet with CCK-8 infusion)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: HFD-CCK (High-Fat Diet with CCK-8 infusion)
Number of subjects: 14

Group type: COMPARATOR
Intervention: ND-SAL (Normal Diet with saline infusion)
Number of subjects: 14
Study: 18719452

Group type: EXPERIMENTAL
Intervention: Pulsed mode radiofrequency
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Continuous mode radiofrequency
Number of subjects: 5

Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 5
Study: 16628152

Group type: EXPERIMENTAL
Intervention: Acupuncture point (AcP) at Stomach‐36
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-AcP region (control)
Number of subjects: 20
Study: 11790641

Group type: EXPERIMENTAL
Intervention: Sertraline (exact dosage and duration not specified)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 9579256

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Face Mask (FM)
Number of subjects: 60
Study: 7714375

Group type: EXPERIMENTAL
Intervention: Preserved group
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-preserved group
Number of subjects: 28
Study: 2641206

Group type: EXPERIMENTAL
Intervention: Trial without catheter (immediate removal after bladder was emptied)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial without catheter (removal 24 hours later)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial without catheter (removal 48 hours later)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial without catheter (overall)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial without catheter (successful patients reviewed 6 months later)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial without catheter (overall conclusion)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial without catheter (recommendation)
Number of subjects: 60
Study: 410296

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Continuous radiation therapy with hydroxyurea
Number of subjects: 130
Study: 7010976

Group type: EXPERIMENTAL
Intervention: Intraaortic balloon counterpulsation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 30
Study: 31784442

Group type: EXPERIMENTAL
Intervention: Acupuncture group (P6 acupuncture)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intradermal thumbtack needle group (P6 intradermal needle)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Acupuncture group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intradermal thumbtack needle group
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 29802649

Group type: EXPERIMENTAL
Intervention: Endurance Training (ET) for 8 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy age‐matched subjects (Control)
Number of subjects: 30
Study: 26875887

Group type: EXPERIMENTAL
Intervention: ACL reconstruction + OA debridement and functional rehabilitation training under arthroscopy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Analgesic, anti-inflammatory drugs + functional rehabilitation training
Number of subjects: 68
Study: 24585701

Group type: EXPERIMENTAL
Intervention: SRI + DIET + EX
Number of subjects: 48

Group type: COMPARATOR
Intervention: DIET + EX
Number of subjects: 48
Study: 22074188

Group type: EXPERIMENTAL
Intervention: Linezolid (2 mg/ml) + heparin (2000 U/ml)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Vancomycin (5 mg/ml) + heparin (2000 U/ml)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Unfractionated heparin (2000 U/ml) alone
Number of subjects: 131
Study: 19349549

Group type: EXPERIMENTAL
Intervention: AC-T-H (doxorubicin, cyclophosphamide, weekly paclitaxel, and trastuzumab)
Number of subjects: 1503

Group type: EXPERIMENTAL
Intervention: AC-TH-H (doxorubicin, cyclophosphamide, weekly paclitaxel, and trastuzumab)
Number of subjects: 1503

Group type: COMPARATOR
Intervention: AC-T (doxorubicin, cyclophosphamide, and weekly paclitaxel)
Number of subjects: 1503
Study: 17932235

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cognitive Therapy (CT)
Number of subjects: 101
Study: 15356676

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP), 40 mg/day, oral medication for 2 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo, oral medication for 2 weeks
Number of subjects: 15
Study: 11994699

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with birch pollen extract
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 9667298

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 30
Study: 7842676

Group type: EXPERIMENTAL
Intervention: Cutting fluid A (4% or 5%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cutting fluid B (4% or 5%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cutting fluid C (4% or 5%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (water probe)
Number of subjects: 10
Study: 2530019

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion (37 pmol min-1 kg-1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 765873

Group type: EXPERIMENTAL
Intervention: High intravenous doses of methylprednisolone (1 g intravenously on alternate days, maximum of four injections)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Increased daily prednisolone doses (300 mg first day, 200 mg second day, 100 mg third day, tapering down over weeks)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High intravenous doses of methylprednisolone
Number of subjects: 48
Study: 31325336

Group type: EXPERIMENTAL
Intervention: Antral Follicle Count (AFC) based gonadotropin dosing
Number of subjects: 200

Group type: COMPARATOR
Intervention: Serum Anti-Müllerian Hormone (AMH) based gonadotropin dosing
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: AFC based gonadotropin dosing
Number of subjects: 200

Group type: COMPARATOR
Intervention: AMH based gonadotropin dosing
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of AFC > 5
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of AFC ≤ 5
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: AFC and AMH categorization
Number of subjects: 200